Synergetics USA, Inc. (NASDAQ: SURG), a leading medical device company
that designs, manufactures, and markets innovative microsurgical
instruments and other devices, today announced the appointment of David
M. Hable as President and Chief Executive Officer, and a member of the
Board of Directors, effective immediately.
Mr. Hable, is a veteran of the medical device industry with over 28
years of experience. As CEO, Mr. Hable will assume responsibility for
the overall management of the Company’s operations.
"The Synergetics’ Board conducted a search for the strongest candidate
to lead the next stage of our growth,” commented Robert Dick, Chairman
of the Board. “The appointment of David as Chief Executive Officer is an
exciting and positive step forward for the Company. David’s substantial
experience and knowledge of the medical device industry will be
invaluable to the continued growth of the Company’s core businesses. His
impressive record of executive level leadership at several medical
device and healthcare companies coupled with his sales and marketing
expertise, makes him the right executive to assume leadership of our
Company.”
Prior to joining Synergetics, Mr. Hable, (53), served as President and
CEO of Afferent Corporation, a venture capital backed medical device
company focused on Neuro Stimulation Therapies. Previously, he was
Chairman of the Board of ONI Medical Systems, Inc., a developer and
marketer of Magnetic Resonance Imaging (MRI) equipment for extremity
applications in non-hospital settings. Mr. Hable also spent over 20
years with Codman & Shurtleff, Inc., a Johnson & Johnson company, which
develops and markets a wide range of diagnostic and therapeutic products
for the treatment of central nervous system disorders. Mr. Hable was
engaged at Codman in several sales and marketing positions. From 1998 to
2003, Mr. Hable served as Codman’s Worldwide President leading all
functions in the Company, both domestically and internationally.
“I am very excited to be a part of the Synergetics’ team,” stated Mr.
Hable. “The Company is well positioned in the microsurgery marketplace
for profitable growth via innovative new product introductions,
operational advances, and an expanded sales network. During these trying
economic times, the Company’s strong commitment to continuous
improvement and teamwork has facilitated a solid record of performance.
I am honored by this appointment and I look forward to leading the
Company in its continued growth.”
About Synergetics USA, Inc.
Synergetics USA, Inc. is a medical device company focused on
microsurgery.
